Natera Inc is a pioneering diagnostics company that offers a wide range of molecular testing services globally. Its innovative portfolio includes Panorama, a non-invasive prenatal test for chromosomal abnormalities, and Horizon, a carrier screening test. Natera also provides Vistara, Spectrum, Anora, Empower, and a non-invasive prenatal paternity product. Additionally, it offers Signatera for cancer recurrence monitoring, Altera for genomic profiling, Prospera for transplant rejection assessment, and Renasight for kidney gene panel testing. Natera enhances its offerings through partnerships and a cloud-based software, Constellation, facilitating access to its advanced algorithms and bioinformatics. Founded in 2003, Natera is headquartered in Austin, Texas.
Management lifted full-year revenue guidance $100 million at the midpoint to $2.85 billion to $2.91 billion after oncology test volumes jumped 57.2% year over year. Signatera's FDA companion diagnostic approval in bladder cancer, plus Japanese and EU clearances, widens the market behind that raise. FIND-CRC enrollment wraps in Q3.
Stanley Druckenmiller is skipping the mega-cap tech herd and loading up on a Mexican discount grocer, an Argentine shale producer, and a biotech that Wall Street just handed a 38% discount despite…
It’s hard to pick just one favorite stock idea for the rest of the year. It’s been a blistering-hot 2026, as the AI revolution keeps rolling ahead. And while memory and storage…
Joey Frenette Billionaire investor Stanley Druckenmiller is known for making bold moves when conviction is high, and his latest portfolio changes suggest he sees a major opportunity developing in one corner of the market.…
Stanley Druckenmiller is a legendary Wall Street investor, and there are very few investors on Wall Street with such an exceptional record. He’s loading up on a stock called Sea (NYSE:SE |…
Citi swept through its life science tools and diagnostics coverage on Wednesday, opening a 90-day upside catalyst watch on Agilent Technologies (NYSE:A | A Price Prediction) while trimming its price target on…
Pre-Market Stock Futures: The futures are trading flat on Wednesday after a second strong day for Wall Street, as the Dow Jones Industrial Average hit another record high, closing over $49,000 for…
Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been winning. He has been piling into Natera (NASDAQ:NTRA | NTRA Price Prediction),…
Prognostications that the AI bubble is grossly overbought have been increasing. The fact that the Magnificent 7 AI stocks, such as Microsoft (NASDAQ: MSFT | MSFT Price Prediction), Apple (NASDAQ: AAPL), Nvidia…
Stanley Druckenmiller has been one of the most successful investors, a billionaire with a long record of high returns in global macro investing. He’s now piling into Natera (NASDAQ:NTRA | NTRA Price…
Cathie Wood’s Ark funds have been really heating up in recent months. Perhaps her most intriguing and underrated fund is the Ark Genomics Revolution ETF (ARKG), which is packed full of extraordinary…
Stanley Druckenmiller is one of those legendary investors who are worth listening to and learning from. The man, who’s worth something in the ballpark of $6.9 billion, has made plenty of smart,…
The last trading day of 2023 got off to a flat start, and the two premier ride-sharing stocks both received downgrades on Friday morning.
